113 related articles for article (PubMed ID: 30138519)
1. Protective effect of pentoxifylline on amikacin-induced ototoxicity.
El-Anwar MW; Abdelmonem S; Nada E; Galhoom D; Abdelsameea AA
Ear Nose Throat J; 2018 Aug; 97(8):E8-E12. PubMed ID: 30138519
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of pentoxifylline on amikacin-induced ototoxicity in rats.
Berkiten G; Salturk Z; Topaloğlu I; Uğraş H
Am J Otolaryngol; 2012; 33(6):689-92. PubMed ID: 22784588
[TBL] [Abstract][Full Text] [Related]
3. Cilostazol Effect on Amikacin-Induced Ototoxicity: An Experimental Study.
El-Anwar MW; Abdelmonem S; Nada E; Galhoom D; Abdelsameea AA
Audiol Neurootol; 2016; 21(4):250-253. PubMed ID: 27576862
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of ethyl pyruvate on amikacin-induced ototoxicity in rats.
Dedeoğlu S; Ayral M
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2460-2466. PubMed ID: 35442461
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of creatine on amikacin-induced ototoxicity.
Apaydın E; Dağlı E; Bayrak S; Kankılıç ES; Şahin H; Acar A
Braz J Otorhinolaryngol; 2022; 88(5):651-656. PubMed ID: 33121925
[TBL] [Abstract][Full Text] [Related]
6. Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats.
Ozer MK; Asci H; Oncu M; Yesilot S; Savran M; Bayram D; Cicek E
Ren Fail; 2009; 31(2):134-9. PubMed ID: 19212910
[TBL] [Abstract][Full Text] [Related]
7. Relationship between amikacin blood concentration and ototoxicity in low birth weight infants.
Endo A; Nemoto A; Hanawa K; Maebayashi Y; Hasebe Y; Kobayashi M; Naito A; Kobayashi Y; Yamamoto S; Isobe K
J Infect Chemother; 2019 Jan; 25(1):17-21. PubMed ID: 30539740
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the protective effect of magnesium on amikacin ototoxicity by electrophysiologic tests in guinea pigs].
Bulut E; Yağiz R; Taş A; Uzun C; Yildirim C; Kaymak K; Karasalioğlu AR
Kulak Burun Bogaz Ihtis Derg; 2005; 15(3-4):70-7. PubMed ID: 16340296
[TBL] [Abstract][Full Text] [Related]
9. Influence of Spirulina platensis and ascorbic acid on amikacin-induced nephrotoxicity in rabbits.
Abdel-Daim MM; Ahmed A; Ijaz H; Abushouk AI; Ahmed H; Negida A; Aleya L; Bungau SG
Environ Sci Pollut Res Int; 2019 Mar; 26(8):8080-8086. PubMed ID: 30685861
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Experimental Study on the Protective Effect of Resveratrol against Amikacin-Induced Ototoxicity in Rats.
Avcı D; Erkan M; Sönmez MF; Kökoğlu K; Güneş MS; Gündoğdu R; Güleç Ş; Karabulut D
J Int Adv Otol; 2016 Dec; 12(3):290-297. PubMed ID: 27810846
[TBL] [Abstract][Full Text] [Related]
11. Ototoxicity caused by once- and twice-daily administration of amikacin in rabbits.
Pavlidis P; Nikolaidis V; Gouveris H; Papadopoulos E; Kekes G; Kouvelas D
Int J Pediatr Otorhinolaryngol; 2010 Apr; 74(4):361-4. PubMed ID: 20089318
[TBL] [Abstract][Full Text] [Related]
12. Amikacin ototoxicity enhanced by Ginkgo biloba extract (EGb 761).
Miman MC; Ozturan O; Iraz M; Erdem T; Olmez E
Hear Res; 2002 Jul; 169(1-2):121-9. PubMed ID: 12121745
[TBL] [Abstract][Full Text] [Related]
13. The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation.
Madbouly N; Azmy A; Salama A; El-Amir A
J Antibiot (Tokyo); 2021 Sep; 74(9):580-592. PubMed ID: 34253885
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of trimetazidine on amikacin-induced ototoxicity in rats.
Aksoy F; Dogan R; Ozturan O; Eren SB; Veyseller B; Pektas A; Hüseyinbas Ö
Int J Pediatr Otorhinolaryngol; 2014 Apr; 78(4):663-9. PubMed ID: 24582075
[TBL] [Abstract][Full Text] [Related]
15. Once-daily dosing of amikacin for treatment of
Lee H; Sohn YM; Ko JY; Lee SY; Jhun BW; Park HY; Jeon K; Kim DH; Kim SY; Choi JE; Moon IJ; Shin SJ; Park HJ; Koh WJ
Int J Tuberc Lung Dis; 2017 Jul; 21(7):818-824. PubMed ID: 28633708
[TBL] [Abstract][Full Text] [Related]
16. Betahistine exacerbates amikacin ototoxicity.
Aksoy F; Dogan R; Ozturan O; Yildirim YS; Veyseller B; Yenigun A; Ozturk B
Ann Otol Rhinol Laryngol; 2015 Apr; 124(4):280-7. PubMed ID: 25358613
[TBL] [Abstract][Full Text] [Related]
17. Circadian variation in amikacin clearance and its effects on efficacy and toxicity in mice with and without immunosuppression.
Hosokawa H; Nyu S; Nakamura K; Mifune K; Nakano S
Chronobiol Int; 1993 Aug; 10(4):259-70. PubMed ID: 8403069
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent dual effect of melatonin on ototoxicity induced by amikacin in adult rats.
Erdem T; Ozturan O; Iraz M; Miman MC; Olmez E
Eur Arch Otorhinolaryngol; 2005 Apr; 262(4):314-21. PubMed ID: 15170574
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Mitoquinone for Protecting Against Amikacin-Induced Ototoxicity in Guinea Pigs.
Dirain CO; Ng MRAV; Milne-Davies B; Joseph JK; Antonelli PJ
Otol Neurotol; 2018 Jan; 39(1):111-118. PubMed ID: 29194212
[TBL] [Abstract][Full Text] [Related]
20. [In the search for effective and safe dose of amikacin in patients with chronic kidney disease].
Gomółka M; Szamotulska K; Rymarz A; Brodowska-Kania D; Dubchak I; Piechota W; Jurkiewicz D; Niemczyk S
Pol Merkur Lekarski; 2014 Apr; 36(214):240-4. PubMed ID: 24868895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
